FDA First-Cycle Approval Rate For NMEs Leaps To 50% In 2003

FDA's effort to increase the rate that drug products are approved by their user fee goal date appears to be paying off, with significant improvement seen in 2003 compared to the year before

More from Archive

More from Pink Sheet